NRO Neurones SA

NEURONES: Organic growth up 5.7% in 1st quarter 2021

NEURONES: Organic growth up 5.7% in 1st quarter 2021

PRESS INFORMATION

Heading: 1st quarter 2021 revenues        Nanterre, May 5, 2021 (after trading)

Organic growth up 5.7% in 1st quarter 2021

(in € millions)Q1 2020Q1 2021growthof which organic
Revenues135.3144.2+6.6%+5.7%

Achievements

With organic growth up 5.7% in the first quarter (compared with 5.4% for the same period last year), the group is back on track with its pre-health crisis performance.

Operating profit (*) amounted to 10.4% of revenues (compared with 9.3% in Q1 2020).

Compared to the 2020 Universal Registration Document ( - Investors), the financial position has not changed significantly.

Outlook

In the favorable context of:

  • a significant proportion of recurring managed services contracts,
  • low exposure to affected sectors,
  • continued acceleration of digital transformation,



NEURONES expects to achieve revenues of around €560m in 2021, with an operating profit of around 9.5%.

(*) not audited and after inclusion of 0.3% of expenses related to bonus shares.

About NEURONES

With 5,700 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD (deferred settlement) mid-caps

Press Relations:

O'Connection

Valérie Hackenheimer

Tel.: +33 (0)6 12 80 35 20







NEURONES

Matthieu Vautier

Tel.: +33 (0)1 41 37 41 37

Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37

Attachment



EN
05/05/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE

NEURONES : Déclaration des transactions sur actions propres (période d...

NEURONES : Déclaration des transactions sur actions propres (période du 23 au 27 mars 2026) Nanterre, le 30 mars 2026 Déclaration des transactions sur actions propres(période du 23 au 27 mars 2026) Dans le cadre du programme de rachat d’actions propres autorisé par l’Assemblée Générale du 5 juin 2025 et confié au CIC, NEURONES a procédé, entre le 23 et le 27 mars 2026, aux achats suivants (code ISIN FR0004050250) : JourVolume total journalier(en nombre d'actions)Prix pondéré moyen(journalier unitaire)23/03/202646 39234,13 €24/03/202642 99333,47 €25/03/202611 66534,58 €26/03/20267 16634,2...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (March 23 to ...

NEURONES: Declaration of transactions on treasury shares (March 23 to 27, 2026) Nanterre, March 30, 2026 Declaration of transactions on treasury shares(period from 23 to 27 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 23 and 27, 2026 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)03/23/202646,39234.13 €03/24/202642,99333.47 €03/25/202611,66534.58 €03/26/20267,16634.26 €03/27/20266,80534.43 €Total115,021  As o...

 PRESS RELEASE

NEURONES : Déclaration des transactions sur actions propres (période d...

NEURONES : Déclaration des transactions sur actions propres (période du 16 au 20 mars 2026) Nanterre, le 23 mars 2026 Déclaration des transactions sur actions propres(période du 16 au 20 mars 2026) Dans le cadre du programme de rachat d’actions propres autorisé par l’Assemblée Générale du 5 juin 2025 et confié au CIC, NEURONES a procédé, entre le 16 et le 20 mars 2026, aux achats suivants (code ISIN FR0004050250) : JourVolume total journalier(en nombre d'actions)Prix pondéré moyen(journalier unitaire)16/03/202632 18634,17 €17/03/20266 80035,09 €18/03/20266 56735,05 €19/03/20266 38434,95 €...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (March 16 to ...

NEURONES: Declaration of transactions on treasury shares (March 16 to 20, 2026) Nanterre, March 23, 2026 Declaration of transactions on treasury shares(period from 16 to 20 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 16 and 20, 2026 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)03/16/202632,186€34.1703/17/20266,800€35.0903/18/20266,567€35,0503/19/20266,384€34,9503/20/202621,011€34,16Total72,948  As of March...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (March 9 to 1...

NEURONES: Declaration of transactions on treasury shares (March 9 to 13, 2026) Nanterre, March 16, 2026 Declaration of transactions on treasury shares(period from 9 to 13 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 9 and 13, 2026 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)03/12/202625,669€36.1003/13/20266,734€34.96Total32,403  As of March 13, 2026, excluding the liquidity contract, NEURONES now holds 42,...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch